Jay M. Edelberg

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

Gregory G. Schwartz, Philippe Gabríel Steg, Michael Szarek et al. · New England Journal of Medicine · 2018 · 3.3K citations · Full text

Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome

Vera Bittner, Michael Szarek, Philip E. Aylward et al. · Journal of the American College of Cardiology · 2020 · 545 citations · Full text

Young Adult Bone Marrow–Derived Endothelial Precursor Cells Restore Aging-Impaired Cardiac Angiogenic Function

Jay M. Edelberg, Lilong Tang, Koichi Hattori et al. · Circulation Research · 2002 · 321 citations

A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state.

Hartmut Weiler-Guettler, Patricia D. Christie, David Beeler et al. · Journal of Clinical Investigation · 1998 · 251 citations · Full text

Immunology, Thrombin Production, Targeted Point Mutation +18

Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome

J. Wouter Jukema, Michael Szarek, Laurien E. Zijlstra et al. · Journal of the American College of Cardiology · 2019 · 225 citations · Full text